Myelofibrosis Neoplasms
Myeloproliferative Neoplasms (MPNs) are a type of cancers in the blood that cause a surplus of white or red blood cells, or platelets, which leads to issues with blood flow. The three types of MPNs include Polycythemia Vera, Essential Thrombocythemia and Myelofibrosis.
According to the Leukemia & Lymphoma Society, Myelofibrosis develops when the bone marrow produces a surplus of blood cells and scar tissue begins to form in the bone marrow. Myelofibrosis can affect anyone, but it is most common for people over the age of 50 and it only affects 1.5 out of every 100,000 people in the U.S. annually.
Massive Bio’s number one priority is to create positive outcomes for cancer patients. With the Clinical Trial Matching Service and Virtual Tumor Board, you are one-step closer to reaching that positive outcome.
Cancer clinical trials are important for cancer treatment; they find and prove new ways to fight cancer. By participating in a clinical trial, you can find the best treatment for your Myelofibrosis Neoplasms and help others who are struggling with Myelofibrosis. Getting access to the right clinical trials and right treatments shouldn’t have to be overwhelming. That’s why Massive Bio uses the clinical trial matching service to match Myelofibrosis patients to the right clinical trials based on the stage of disease, biomarker status, geographical location and past medical history.
Why Join A Myelofibrosis Neoplasms Clinical Trial?
Clinical trials for myelofibrosis and myeloproliferative neoplasms provide access to brand new therapies that are evaluated by the FDA (Food and Drug Administration). Clinical trials are conducted to evaluate the efficacy and safety of clinical research in order to prevent, treat, or diagnose cancer.
Massive Bio’s SYNERGY-AI Clinical Trial Matching System matches patients to clinical trials based on their individual cancer case. By using 100 data points including location, cancer type, stage, and biomarker status, cancer patients will be matched with the trials that are most suitable for them.
Effects of Myelofibrosis Neoplasms
-
Fatigue
Feeling of tiredness, weakness, or shortness of breath from anemia. -
Easy bleeding
Myelofibrosis patients may bleed or bruise easily. -
Uncomfortable feeling in the abdomen
Enlarged spleen can cause pain or fullness on the lower left side of the body.
Benefits
Find Myelofibrosis Neoplasms Clinical Trials
Massive Bio’s virtual matching system can do all the leg work for you. Our team finds the most suitable clinical trial options for you virtually, while you wait safely in your home, avoiding travel until a trial is picked and the enrollment process is complete. When your results with matching clinical trials are ready, our experienced patient advocate will help you through the process of enrolling in the trial and will even help get over any hurdles that arise throughout the process. Our goal is to help cancer patients connect with the latest in cancer treatment to create positive outcomes for their case. Contact us today to learn more about how we help cancer patients access new treatments through clinical trials.
Find Cancer Clinical Trial
Do You Have Any Questions?
- Be one step closer to finding myelofibrosis neoplasms treatments.
- A second opinion without leaving home by US oncologists.
- If you have relapsed, or current therapy has failed, there are more options for you.
- Access to clinical trials & immunotherapy treatment options.
Testimonials
So far, my experience with Massive Bio has been very positive. My initial interaction with case manager was informative and he provide me with the proper forms to be completed. The initial report and clinical trial recommendations was excellent. The report provided a details summary of my complete cancer medical history including test results, chemotherapy treatments (which revealed an error in the history on file at one medical institution), and procedures. My follow up conversation with oncology nurse was professional, informative and educational. She spent a lot of time with me reviewing the clinical trial options, answering my questions on my current chemotherapy treatment regiment, and was proactive regarding follow up and next steps. I look forward to working with Massive Bio on my current cancer journey and hope that they can assist me with combatting and winning this battle.
MICHAEL L.
The service Massive Bio provides is very special, going beyond other oncology services. They combine second opinion and precision oncology, taking into consideration patients’ requests and previous treatments. They provide reports from US-based physicians within a week; the diagnosis and treatment suggestions their doctors and team recommend are really personalized and sophisticated. I wish every cancer patient could get an evaluation from Massive Bio. There is absolutely no need to look for another expert service in cancer treatment advisory other than Massive Bio. I congratulate the team that now provides new opportunities for cancer patients.
FUAT ABUT
Dealing with a cancer, where all the standard options are limited, Massive Bio helped make the case for new immunotherapy which was selected specifically based on my my mother’s treatment challenges. When our oncologist left, Massive Bio took us that much further.
LISA B.
Join this Myelofibrosis Facebook Group for Community Support
Patient's recently diagnosed or relapsed with Myelofibrosis may wonder what the right next step to take is. Join a community of others who are going through Myelofibrosis to discuss questions, concerns, and share stories
Frequently Asked Questions Related to Myelofibrosis Neoplasms
- The CTMS can be accessed here and our mobile app, SYNERGY-AI Cancer Trial Finder, which is available on both Google Play and the IOS App Store.
- We request patients’ medical records virtually through fax.
- We send clinical trial matching reports directly to patients by email within 7-10 business days of receiving the required medical records.
- We will contact you to discuss your clinical trial match report and the next steps needed in order to enroll in the desired trial.
- The process is entirely virtual until the enrollment process is completed, and the first appointment is scheduled at the clinical trial site.